What are the new CMV screening guidelines for pregnant women?

The new CMV screening guidelines focus on targeted testing for pregnant women who show potential symptoms or have specific risk factors, rather than universal screening. This approach aims to identify infections more consistently during prenatal care, where CMV has historically been overlooked. The guidelines provide a clear roadmap for healthcare providers on when to test—typically when a pregnant woman presents with flu-like symptoms, mononucleosis-like illness, or has occupational exposure (such as working with young children). They also standardize how to interpret test results and outline subsequent steps, including confirmatory testing and monitoring. This targeted strategy helps balance early detection with practical implementation, ensuring resources are directed toward those at highest risk while avoiding unnecessary anxiety and costs for low-risk pregnancies. The emphasis is on integrating CMV screening into routine prenatal care protocols to bridge the gap in congenital infection prevention.

📖 Read the full article: New CMV Pregnancy Guidelines & Treatment Coverage Push